Why are current genomic testing models based on targeted sequencing (

Why are current genomic testing models based on targeted sequencing ("Hot Spot") unsustainable given what we know about genomically-targeted therapy?

Why are current genomic testing models based on targeted sequencing (“Hot Spot”) unsustainable given what we know about genomically-targeted therapy; and why have comprehensive genomic profiling (CGP) NGS platforms, such as those developed by FoundationOne, that perform multi-gene testing become preeminent?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Klempner, MD

Samuel Klempner, MD

Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, CA